Skin cancer self-detection education: does framing affect outcomes?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two educational approaches for skin cancer self-detection and prevention against a wait-list control. The program delivers tailored, web-based content for adults 16 and older, focusing on skin of color and culturally relevant messaging. Participants are randomized to gain-framed, loss-framed education, or a wait-list control, and outcomes include knowledge, detection behaviors, and sun protection practices. The study aims to determine if framing influences adherence to protective behaviors and early detection, with implications for reducing morbidity and mortality from skin cancer in diverse populations. The intervention acknowledges Western-centric tools and adapts messaging to better reflect skin of color presentations, such as acral lentiginous melanomas.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals aged 16 and above
* Able to read and converse in English
* Able to provide informed consent
* Having the ability to use and interact with a web server or application.

Exclusion Criteria:

\- Individuals who have cognitive impairment or decline to participate. There will be no exclusion criteria based on a previous history of skin cancer.

Where it's running

• National University Hospital
  Singapore, Singapore Recruiting

Study contacts

• Principal investigator: Ellie Choi, MBBS — National University Hospital, Singapore
• Study coordinator: Ellie Choi, MBBS
• Email: dermresearchec@nuhs.edu.sg
• Phone: 65 6908 2222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early skin tumor detection with telemedicine in primary care

  This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.

  Recruiting at 2 sites Institute of Health Information and Statistics of the Czech Republic · Brno and 4 other locations · NCT07349940

• Mobile sun protection support to help young adults stay safe in the sun

  This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07830394

• Sun Safe Together: a digital skin cancer prevention approach for teens and their parents

  A small, single-arm trial will test whether a 12-week digital program using teen MMS messages and a private Facebook group for parents can feasibly and acceptably improve sun safety among adolescents and their parents.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey · NCT07681791

• Psycho-physiological profiling of people with low versus high heat resilience

  This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.

  Recruiting at 2 sites University of Thessaly · Copenhagen and 1 other locations · NCT07510061

• Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers

  This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.

  Recruiting at 2 sites Phase 4 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07426484

• First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia

  This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07422779

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.